日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study

FAAP模型在接受TACE、信迪利单抗联合贝伐珠单抗治疗的肝细胞癌患者预后分层中的开发和验证:一项多中心研究

Ren, Liying; Chen, Dongbo; Zhang, Xue; She, Shaoping; Fei, Ran; Cong, Xu; Mu, Shaowei; Zhou, Yuchen; Gao, Jie; Liao, Weijia; Chen, Hongsong

Hemopexin Suppresses Hepatocellular Carcinoma via TNF-α-Mediated Mitochondrial Apoptosis.

血红素结合蛋白通过TNF-α介导的线粒体凋亡抑制肝细胞癌。

Ren Liying, Man Yuxin, Zhang Xue, Guo Qian, She Shaoping, Yang Yao, Fei Ran, Cong Xu, Chen Dongbo, Wei Wen, Chen Hongsong

Transparent and dynamic network-based risk assessment for development of hepatic encephalopathy

基于网络的透明、动态肝性脑病风险评估

Wang, Zixing; Jiang, Suzhen; Liu, Feng; Wang, Xiao Xiao; Wang, Guangchuan; Huang, Rui; Kong, Xiangsha; Fei, Ran; Li, Xiaohe; Cao, Jinming; Yang, Shuo; Wu, Nan; Chen, Dongbo; She, Shaoping; Han, Wei; Hu, Yaoda; Wen, Xin; Xue, Tianyi; Song, Guangjun; Rao, Huiying

Bridging the Gap Between Imaging and Molecular Characterization: Current Understanding of Radiomics and Radiogenomics in Hepatocellular Carcinoma

弥合影像学与分子表征之间的差距:目前对肝细胞癌放射组学和放射基因组学的理解

Ren, Liying; Chen, Dong Bo; Yan, Xuanzhi; She, Shaoping; Yang, Yao; Zhang, Xue; Liao, Weijia; Chen, Hongsong

Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen

利用共表达患者HLA和抗原的单质粒系统验证肝细胞癌中的优势新抗原

Chen, Pu; Chen, Dongbo; Bu, Dechao; Gao, Jie; Qin, Wanying; Deng, Kangjian; Ren, Liying; She, Shaoping; Xu, Wentao; Yang, Yao; Xie, Xingwang; Liao, Weijia; Chen, Hongsong

Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment

前列腺癌中PC3分泌微蛋白(PSMP)表达水平升高与异种移植瘤生长增加和免疫相关微环境改变相关

Pei, Xiaolei; Zheng, Danfeng; She, Shaoping; Fang, Zhiwei; Zhang, Shiying; Hu, Hao; Xu, Kexin; Wang, Ying